HomeAQS • CVE
Follow
Aequus Pharmaceuticals Inc
Previous close
$0.015
Day range
$0.010 - $0.010
Year range
$0.010 - $0.060
Market cap
994.76K CAD
Avg Volume
37.79K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
(CAD) | Sep 2023info | Y/Y change |
---|---|---|
Revenue | 13.36K | -96.16% |
Operating expense | 774.83K | -8.81% |
Net income | -803.65K | -60.58% |
Net profit margin | -6.02K | -4,082.01% |
Earnings per share | — | — |
EBITDA | -770.26K | -46.81% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(CAD) | Sep 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 112.02K | -86.16% |
Total assets | 1.17M | -56.16% |
Total liabilities | 4.76M | 56.71% |
Total equity | -3.59M | — |
Shares outstanding | 132.63M | — |
Price to book | -0.50 | — |
Return on assets | -187.65% | — |
Return on capital | -368.95% | — |
Cash Flow
Net change in cash
(CAD) | Sep 2023info | Y/Y change |
---|---|---|
Net income | -803.65K | -60.58% |
Cash from operations | -649.73K | -20.54% |
Cash from investing | — | — |
Cash from financing | 731.36K | 2,038.92% |
Net change in cash | 81.63K | 114.15% |
Free cash flow | -367.41K | -6.70% |
About
Founded
2013
Headquarters
Website
Employees
12